SerLect

SerLect Uses, Dosage, Side Effects, Food Interaction and all others data.

SerLect, a neuroleptic, is one of the newer antipsychotic medications available. Serdolect is developed by the Danish pharmaceutical company H. Lundbeck. It is a phenylindole derivative used in the treatment of schizophrenia. It was first marketed in 1996 in several European countries before being withdrawn two years later because of numerous cardiac adverse effects. It has once again been approved and should soon be available on the French and Australian market.

SerLect is an atypical antipsychotic at least as effective as haloperidol and risperidone in the treatment of neuroleptic-responsive schizophrenia. SerLect improves negative symptoms, and is also effective for the treatment of neuroleptic-resistant schizophrenia. SerLect is generally well tolerated and is associated with a low rate of extrapyramidal symptoms (EPS).

Trade Name SerLect
Generic Sertindole
Sertindole Other Names Sertindol, Sertindole, Sertindolum
Type
Formula C24H26ClFN4O
Weight Average: 440.941
Monoisotopic: 440.177917386
Groups Approved, Investigational, Withdrawn
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
SerLect
SerLect

Uses

SerLect is an atypical antipsychotic indicated in the treatment of schizophrenia.

Used in the treatment of schizophrenia.

SerLect is also used to associated treatment for these conditions: Schizophrenia

How SerLect works

SerLect is an antipsychotic drug with affinity for dopamine D2, serotonin 5-HT2A and 5-HT2C, and alpha1-adrenoreceptors. Preclinical studies suggest that sertindole acts preferentially on limbic and cortical dopaminergic neurons and clinical trials have confirmed that sertindole is effective at a low dopamine D2 occupancy level.

Elimination Route

Orally available.

Half Life

3 days

Innovators Monograph

You find simplified version here SerLect

*** Taking medicines without doctor's advice can cause long-term problems.
Share